Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
0.6913
+0.0713 (11.50%)
At close: Jun 29, 2026, 4:00 PM EDT
0.6910
-0.0003 (-0.04%)
After-hours: Jun 29, 2026, 6:32 PM EDT
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $64.28 million as of June 29, 2026. Its market cap has decreased by -38.89% in one year.
Market Cap
64.28M
Enterprise Value
59.47M
1-Year Change
-38.89%
Ranking
Category
Stock Price
$0.69
Market Cap Chart
Since December 8, 2022, Citius Oncology's market cap has decreased from $90.21M to $64.28M, a decrease of -28.75%. That is a compound annual growth rate of -9.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 64.28M | -24.20% |
| Dec 31, 2025 | 84.80M | 3.05% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
| Dec 8, 2022 | 90.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BGM Group | 124.06M |
| Cardiol Therapeutics | 122.68M |
| Cumberland Pharmaceuticals | 101.14M |
| InterCure | 57.73M |
| Talphera | 53.46M |
| Incannex Healthcare | 40.92M |
| BioXcel Therapeutics | 40.45M |
| SCYNEXIS | 38.23M |